1 / 5

Personalized Gene Therapy Treatments for Cancer Market : Quantitative Market Analysis, Current and Future Trends

Gene therapy involves insertion of genetic material into cells of the patients to provide them a new function or to restore the missing or inappropriate functioning of the cells due to cancer or gene mutations.

5186
Download Presentation

Personalized Gene Therapy Treatments for Cancer Market : Quantitative Market Analysis, Current and Future Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Personalized Gene Therapy Treatments for Cancer Personalized Gene Therapy Treatments for Cancer Market : Quantitative Market Analysis, Current and Market : Quantitative Market Analysis, Current and Future Trends Future Trends Gene therapy involves insertion of genetic material into cells of the patients to provide them a new function or to restore the missing or inappropriate functioning of the cells due to cancer or gene mutations. Scientists have created personalized medicines that are used to learn about a person’s genetic makeup and untangle the biologic nature of the patient’s cancerous cells for carrying out such therapies. Depending on the type of therapy, personalized gene therapy treatments for cancer market is differentiated into two segments which are as follows: • Targeted treatments • Pharmacogenomics Request For Sample Report: Request For Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/60 https://www.coherentmarketinsights.com/insight/request-sample/60 On the basis of application, the personalized gene therapy treatments for cancer market is analyzed into: • Breast Cancer • Leukemia • Head & Neck Cancer • Prostate Cancer • Pancreatic Cancer • Leukemia Cancer • Melanoma • Ovarian Cancer • Brain Cancer • Colorectal Cancer

  2. • Lung Cancer • Liver Cancer • Bladder Cancer • Lymphoma   Personalized Gene Therapy Treatments for Cancer Market Potential Applications Personalized Gene Therapy Treatments for Cancer Market Potential Applications Targeted treatments are focused on cancer specific genes, tissues or the protein environment that contribute towards the cancer survival and growth. Researchers identify new targeted cells and develop and test new drugs and medications for such targets as per patient needs. In targeted treatments, the tumor cells themselves are targeted to cure cancer. Breast cancer, gastrointestinal stromal tumor, colorectal cancer, kidney cancer, melanoma, lung cancer, brain cancer, multiple myeloma, certain childhood cancers and lymphoma, and leukemia are the common types of cancers for which targeted treatments are applied. Pharmacogenomics Pharmacogenomics, on the other hand, affect the processes occurring in the body and drug responses. The difference in the processes influences the safety and efficacy of a drug. The basic principle behind the treatment is to activate the immune system cells that could attack and destroy the cancerous cells. Moreover, in this case, if the patients’ body does not respond to a medication, the drugs stay in the blood stream for longer period of time and may cause severe side effects. Therefore, this type of treatment carries a risk of reaction of drug from person to person, providing targeted treatment a preference over pharmacogenomics. Personalized gene therapy treatments for cancer market involves evaluation of the developed drugs through clinical trials. Government support and funding and the advantages of personalized gene therapy over other treatment options such as chemotherapy and surgery are the major factors which are projected to drive growth of personalized gene therapy treatments for cancer market. For instance, the U.S. government has set up the MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy in Texas to support preclinical research and clinical trials for targeted therapy for particular genes. Such government initiatives are encouraging researchers to develop more effective personalized gene therapy treatments for different types of cancer, thus boosting growth of the cancer personalized gene therapy treatments market. However, high costs associated with these treatments and the unavailability of personalized gene therapy treatment for some types of cancers is the major

  3. factor that is projected to restrain growth of the personalized gene therapy treatments for cancer market. Geographically, the personalized gene therapy treatments for cancer market has been analyzed into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The major players in the customized gene therapy treatments for cancer market include Amgen, Inc., SynerGene Therapeutics, Inc., Chengdu Shi Endor Biological Engineering Technology Co., Ltd., Cold Genesys, Inc., Takara Bio, Inc., Bellicum Pharmaceuticals, Inc., Ziopharm Oncology, Inc., OncoSec Medical, Inc., Sevion Therapeutics, Inc., and Burzynski Clinic. Key Developments Key Developments Major government bodies and NGOs are focused on supporting R&D in personalized gene therapies for cancer. For instance, in August 2019, The National Cancer Institute of the National Institutes of Health (US) awarded Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis with a US$ 15 million grant in a research to investigate the genetic changes that cause acute myeloid leukemia. Similarly, in August 2019, The Leukemia & Lymphoma Society (LLS) increased pediatric cancer research funding through US$ 50 million Children’s Initiative by adding 20 new grants valued at over US$ 13.8 million to its 2019 portfolio. The LLS aims for the treatment of leukemia & lymphoma patients with multiple targeted therapies simultaneously at up to 200 clinical sites worldwide. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Personalized Gene Therapy Treatments for Cancer Market Research Objective and Assumption • Personalized Gene Therapy Treatments for Cancer Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Personalized Gene Therapy Treatments for Cancer Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Personalized Gene Therapy Treatments for Cancer Market, By Regions • Personalized Gene Therapy Treatments for Cancer Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Personalized Gene Therapy Treatments for Cancer Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors.

  4. • Personalized Gene Therapy Treatments for Cancer Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Personalized Gene Therapy Treatments for Cancer Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion To Get Instant Access, Purchase This Report Here: To Get Instant Access, Purchase This Report Here: https://www.coherentmarketinsights.com/insight/buy-now/1217 https://www.coherentmarketinsights.com/insight/buy-now/1217 To Get Instant Access, Purchase Report Here @ To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/ buy-now/60 buy-now/60 https://www.coherentmarketinsights.com/insight/ Major institutes are focused on R&D of novel approaches in personalized gene therapies for cancer. For instance, in August 2019, researchers from the Institute of Cancer Research, London, reported use of Artificial Intelligence and Machine Learning to identity five new subtypes of breast cancer. The development reported in the journal NPJ Breast Cancer is expected to aid in development of personalized diagnostics and gene therapies. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us

  5. Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related